Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL482465 | 0.88 | CA12 (0.48) | CA12CA1CA9CA2CA7 | |
| SCHEMBL9065504 | 0.88 | CA12 (0.57) | CA12CA1CA9CA2CA7 | |
| SCHEMBL472165 | 0.88 | CA12 (0.57) | CA12CA1CA9CA2CA7 | |
| SCHEMBL28922902 | 0.85 | CA12 (0.47) | CA12CA1CA9CA2CA7 | |
| SCHEMBL25676372 | 0.82 | CA12 (0.52) | CA12CA1CA9CA2CA7 | |
| SCHEMBL6883786 | 0.81 | SIRT1 (0.40) | CA12CA1CA9MAPTALDH1A1 | |
| 1,4-Diallyloxybenzene SCHEMBL302448 | 0.81 | CA12 (0.63) | CA12CA1CA9CA2CA7 | |
| SCHEMBL27583924 | 0.81 | MMP2 (0.36) | CA12CA1CA9CA2CA7 | |
| SCHEMBL472119 | 0.80 | BACE1 (0.51) | CA12CA1CA9CA2CA7 | |
| SCHEMBL2356935 | 0.79 | MMP2 (0.50) | CA12CA1CA9CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3617758-B1 | COMPOSITION FOR FORMING OPTICAL WAVEGUIDE WHICH CONTAINS REACTIVE SILSESQUIOXANE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2023-08-09 | — | — | EP | disclosed |
| US-11333800-B2 | Optical waveguide-forming composition which contains reactive silsesquioxane compound | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-17 | — | — | US | disclosed |
| US-10899891-B2 | Reactive polysiloxane and polymerizable composition comprising same | NISSAN CHEMICAL CORPORATION (JP) | 2021-01-26 | — | — | US | disclosed |
| US-10894800-B2 | Polymerizable silane compound | NISSAN CHEMICAL CORPORATION (JP) | 2021-01-19 | — | — | US | disclosed |
| EP-3466956-B1 | POLYMERIZABLE SILANE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2020-12-09 | — | — | EP | disclosed |
| US-10787535-B2 | Polymerizable composition containing reactive silsesquioxane compound containing phenanthrene ring | NISSAN CHEMICAL CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| EP-3466994-B1 | REACTIVE POLYSILOXANE AND POLYMERIZABLE COMPOSITION CONTAINING SAME | NISSAN CHEMICAL CORP (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-20200148875-A1 | OPTICAL WAVEGUIDE-FORMING COMPOSITION WHICH CONTAINS REACTIVE SILSESQUIOXANE COMPOUND | NISSAN CHEMICAL CORPORATION (JP) | 2020-05-14 | — | — | US | disclosed |
| EP-3373051-B1 | COMPOSITION FOR FORMING OPTICAL WAVEGUIDE | NISSAN CHEMICAL CORP (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-3367144-B1 | MANUFACTURING METHOD FOR GI OPTICAL WAVEGUIDE | NISSAN CHEMICAL CORP (JP) | 2020-03-04 | — | — | EP | disclosed |
| EP-3466956-A1 | POLYMERIZABLE SILANE COMPOUND | Nissan Chemical Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| EP-3466994-A1 | REACTIVE POLYSILOXANE AND POLYMERIZABLE COMPOSITION CONTAINING SAME | Nissan Chemical Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-10253126-B2 | Optical waveguide-forming composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-04-09 | — | — | US | disclosed |
| EP-3444284-A1 | POLYMERIZABLE COMPOSITION CONTAINING REACTIVE SILSESQUIOXANE COMPOUND CONTAINING PHENANTHRENE RING | Nissan Chemical Corporation (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-20180305488-A1 | OPTICAL WAVEGUIDE-FORMING COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-10-25 | — | — | US | disclosed |
| EP-3373051-A1 | COMPOSITION FOR FORMING OPTICAL WAVEGUIDE | Nissan Chemical Industries, Ltd. (JP) | 2018-09-12 | — | — | EP | disclosed |
| EP-3367144-A1 | MANUFACTURING METHOD FOR GI OPTICAL WAVEGUIDE | Nissan Chemical Industries, Ltd. (JP) | 2018-08-29 | — | — | EP | disclosed |
| EP-3327049-A1 | REACTIVE SILSESQUIOXANE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING AROMATIC VINYL COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20180079849-A1 | POLYMERIZABLE RESIN COMPOSITION CONTAINING REACTIVE SILSESQUIOXANE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-03-22 | — | — | US | disclosed |
| EP-3281959-A1 | POLYMERIZABLE RESIN COMPOSITION CONTAINING REACTIVE SILSESQUIOXANE COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2018-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894800-B2 | Polymerizable silane compound | PCNA, ARL1, CCNE1 | CA12 4163/4885CA1 3279/4885CA9 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.